CRIS Current Research Information System

BORSI, ENRICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.357
NA - Nord America 2.932
EU - Europa 2.100
AF - Africa 207
SA - Sud America 171
Continente sconosciuto - Info sul continente non disponibili 147
OC - Oceania 5
Totale 8.919
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.850
VN - Vietnam 1.089
CN - Cina 805
SG - Singapore 760
IT - Italia 682
GB - Regno Unito 332
DE - Germania 231
HK - Hong Kong 201
SE - Svezia 185
IN - India 137
BR - Brasile 128
FR - Francia 128
NL - Olanda 126
KR - Corea 108
RU - Federazione Russa 97
BD - Bangladesh 80
IE - Irlanda 67
CI - Costa d'Avorio 64
FI - Finlandia 48
ZA - Sudafrica 45
JP - Giappone 37
CA - Canada 36
TG - Togo 35
SC - Seychelles 32
EE - Estonia 26
BG - Bulgaria 25
CH - Svizzera 24
AT - Austria 23
PL - Polonia 23
MX - Messico 21
PH - Filippine 20
ES - Italia 19
AR - Argentina 18
UA - Ucraina 18
IR - Iran 16
NG - Nigeria 16
TH - Thailandia 16
TW - Taiwan 14
BE - Belgio 13
ID - Indonesia 12
IQ - Iraq 12
JM - Giamaica 8
JO - Giordania 8
RO - Romania 8
CO - Colombia 7
EC - Ecuador 7
SA - Arabia Saudita 7
TR - Turchia 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
GT - Guatemala 5
LT - Lituania 5
UZ - Uzbekistan 5
AU - Australia 4
GR - Grecia 4
VE - Venezuela 4
CL - Cile 3
CY - Cipro 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
LB - Libano 2
MA - Marocco 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
TN - Tunisia 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
Totale 8.769
Salva come PNG Salva come JPEG
Città #
Singapore 528
Ashburn 361
Ho Chi Minh City 311
Southend 282
Chandler 247
Hanoi 238
Hefei 218
Fairfield 204
San Jose 201
Hong Kong 195
Bologna 172
Ann Arbor 106
Seoul 103
Dallas 94
Wilmington 89
Beijing 88
Houston 85
Woodbridge 84
Seattle 79
New York 73
Princeton 68
Cambridge 67
Dublin 67
Abidjan 64
Santa Clara 61
Boardman 53
Los Angeles 53
Lauterbourg 50
Milan 47
Dong Ket 45
Haiphong 39
Lomé 35
Helsinki 34
Hyderabad 32
Munich 32
Nanjing 32
Tokyo 31
Westminster 28
Padova 26
Council Bluffs 25
Frankfurt am Main 24
Sofia 24
Bremen 23
Fabriano 23
São Paulo 23
Berlin 22
Rome 22
Bengaluru 21
Da Nang 21
Amsterdam 20
Guangzhou 20
Redondo Beach 20
Salsomaggiore Terme 20
Buffalo 19
Biên Hòa 18
Bern 17
Jinan 17
Turin 17
Chicago 16
Vienna 16
Can Tho 15
Redmond 15
Warsaw 15
Ha Long 14
Nanchang 14
Saint Petersburg 14
Abeokuta 13
Quận Bình Thạnh 13
Shanghai 13
Shenyang 13
Toronto 13
Brussels 12
Johannesburg 12
Medford 12
Thái Nguyên 12
Washington 12
Falkenstein 11
Hebei 11
Lappeenranta 11
London 11
Ninh Bình 11
Redwood City 11
Tianjin 11
Changsha 10
Quận Một 10
Brooklyn 9
Mondolfo 9
Naples 9
Nuremberg 9
Amman 8
Falls Church 8
Florence 8
Hải Dương 8
Paris 8
San Diego 8
Tongling 8
Wuhan 8
Yubileyny 8
Zhengzhou 8
Bến Tre 7
Totale 5.482
Salva come PNG Salva come JPEG
Nome #
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 718
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles 334
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment 272
The genetic and genomic background of multiple myeloma patients achieving complete response after induction therapy with bortezomib, thalidomide and dexamethasone (VTD) 237
Treatment optimization for Multiple Myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in an in vitro and ex-vivo model 237
Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells 220
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 213
Inter-Cell Networking Profiling Enables Comprehensive Characterization of Immune-Mediated Activity of Anti-CD38 Therapy through Ex-Vivo Analysis of Multiple Myeloma Patients 209
Circulating Multiple Myeloma Cells (CMMCs) as Prognostic and Predictive Markers in Multiple Myeloma and Smouldering MM Patients 208
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment 204
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens 201
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosis 200
Hypoxia inducible factor-1 alpha as a therapeutic target in multiple myeloma. 197
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 194
Gadd45a transcriptional induction elicited by the Aurora kinase inhibitor MK-0457 in Bcr-Abl-expressing cells is driven by Oct-1 transcription factor 189
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia 187
Maintenance therapy with bortezomib and dexamethasone after autotransplantation for high-risk multiple myeloma 186
High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis 183
PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma 179
Cap dependent translation contributes to resistance of myeloma cells to bortezomib 176
HIF 1 Alpha: A Suitable Target for Multiple Myeloma 176
Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma 175
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 173
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients 171
HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA 169
High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53 168
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 167
Genomic characterization of the putative myeloma stem cells clone reveals alterations possibly correlated with the origin of disease. 164
Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5 162
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma 159
A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies 156
High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53 155
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features 154
Relative role ofAPCandMUTYHmutations in the pathogenesis of familial adenomatous polyposis 150
Analysis of mismatch repair gene mutations in Turkish HNPCC patients 146
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 145
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma 144
Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma 141
Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis”, caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients 139
SIRT regulates the molecular interaction between c-MYC and HIF-1 alpha in multiple myeloma 135
Impact Of p53 Impaired Function On Outcomes Of Multiple Myeloma Patients Carrying Deleted TP53 and/Or Amplified MDM4 132
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma 123
Italian cancer figures, report 2012: Cancer in children and adolescents. 123
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients]. 102
AIRTUM numbers: 200,000 young Italians live with cancer 102
[Italian cancer figures, report 2011: Survival of cancer patients in Italy]. 99
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival 95
Loss of nuclear beta catenin, following chibby enforced expression, activates endoplasmic reticulum stress in cells expressing the BCR-ABL1 fusion gene of chronic myeloid leukemia 87
IMPLEMENTATION OF NEXT GENERATION SEQUENCING AS BEST TOOL FOR ROUTINE EVALUATION OF MINIMAL RESIDUAL DISEASE IN THE DAILY PRACTICE OF MULTIPLE MYELOMA PATIENTS 87
Monoclonal and polyclonal circulating plasma cells (CPCs) are linked to disease spread in multiple myeloma 76
Totale 8.919
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.869
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022673 0 36 41 39 64 39 18 38 42 95 116 145
2022/2023961 75 128 36 147 77 78 29 46 138 55 78 74
2023/2024435 31 44 45 36 29 83 24 80 11 12 24 16
2024/20251.270 79 129 103 109 115 56 96 47 33 128 120 255
2025/20263.952 341 850 287 286 343 144 308 143 674 239 181 156
2026/2027168 113 55 0 0 0 0 0 0 0 0 0 0
Totale 8.919